Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00975845 · ClinicalTrials.gov registry record
BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study
A clinical trial, sponsored by RTI Surgical.
- Completed
- Registry status
- 40
- Enrollment target
NCT00975845 is a clinical trial that has completed, run by RTI Surgical. The registered enrollment target is 40 participants.
The verdict
NCT00975845 has completed, sponsored by RTI Surgical.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
To compare the outcome of Anterior Cruciate Ligament (ACL) reconstruction performed using the tibialis allograft to historical outcomes of ACL reconstruction patients and to establish if any correlation exists between the age of the graft donor and the clinical outcomes.
Interventions
- OTHER BioCleanse Tibialis tendon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-11-09 |
| Est. Completion | 2017-11-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00975845
The ClinicalTrials.gov registry entry for NCT00975845 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RTI Surgical, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BioCleanse Tibialis tendon is the first listed.
NCT00975845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00975845 about?
NCT00975845 is a clinical study titled "BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study". To compare the outcome of Anterior Cruciate Ligament (ACL) reconstruction performed using the tibialis allograft to historical outcomes of ACL reconstruction patients and to establish if any correlation exists between the age of the graft donor and the clinical outcomes.
What is the current status of trial NCT00975845?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2017-11-09. Estimated completion is 2017-11-09.
What interventions are being tested in trial NCT00975845?
The interventions under investigation include: BioCleanse Tibialis tendon (OTHER).
Who is sponsoring clinical trial NCT00975845?
This trial is sponsored by RTI Surgical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.